NCT04200820 is a NA clinical trial of Trampoline in Vestibular Function Tests, sponsored by University of Zurich.

Who is sponsoring NCT04200820?

NCT04200820 is sponsored by University of Zurich.

What drugs are being tested in NCT04200820?

Interventions in NCT04200820: Trampoline.

What condition does NCT04200820 study?

NCT04200820 studies Vestibular Function Tests.

Is NCT04200820 still recruiting?

NCT04200820 is currently completed. Last updated 27 May 2020.

Last reviewed 2020-05-27 · How we verify

NCT04200820

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Changing Vertical Self-motion Perception

Completed NA Last updated 27 May 2020

What this trial tests

NA trial testing Trampoline in Vestibular Function Tests in 20 participants. Completed in 10 March 2020.

Timeline

5 December 2019

Primary endpoint
1 March 2020

10 March 2020

Quick facts

Lead sponsor	University of Zurich
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	20
Start date	5 December 2019
Primary completion	1 March 2020
Estimated completion	10 March 2020
Sites	1 location across Switzerland

Drugs / interventions tested

Trampoline

Conditions studied

Vestibular Function Tests — all drugs for Vestibular Function Tests →

Sponsor

University of Zurich

Who can join

Adults 18 to 30, any sex, with Vestibular Function Tests. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to explore the "vertical self-motion perception" on in healthy young individuals using an elevator as accelerator. Secondary aim is to explore the effects of repeated vertical acceleration on vertical vestibular sensibility.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Earth-vertical motion perception assessment using an elevator: a feasibility study.
Schellenberg S, Straumann D, Green DA, Schuetz P, et al · · 2023 · PMID 37296287 · DOI 10.1038/s41598-023-36655-7

Verify or expand the search:

Other University of Zurich trials

Trials by the same sponsor.

NCT07485699 — Soy Processing and Food Allergy · NA · not yet recruiting
NCT07516912 — Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland · not yet recruiting
NCT07473115 — Individualized Analgesia in the Intensive Care Unit With a New Pain Assessment Bundle and Protocolized Analgesia Adjustm · not yet recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT06481982 — Value of Advanced MRI Techniques in the Assessment of Endometriosis · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04200820 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Zurich
Last refreshed: 27 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04200820.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing